2016-2020 Lyme Disease Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, Europe (France, Germany, Italy, Spain, UK), Japan
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
-Physician Offices - Public Health Labs
I. INTRODUCTION
II. LYME DISEASE WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Elitech Group
Eiken Chemical
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. LYME DISEASE WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Elitech Group
Eiken Chemical
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Lyme Disease Tests
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Germany Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Lyme Disease Tests
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Germany Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier